Jasreman Dhillon

Title: Jasreman Dhillon: Innovator in Cancer Research

Introduction

Jasreman Dhillon is a notable inventor based in Tampa, FL (US). He has made significant contributions to the field of cancer research, particularly in distinguishing between different types of carcinomas. His innovative approach has the potential to improve diagnostic accuracy and patient outcomes.

Latest Patents

Jasreman Dhillon holds a patent for a method of distinguishing urothelial carcinoma from lung and head and neck squamous cell carcinoma. This method involves a 19-gene signature that differentiates between metastatic urothelial carcinoma and squamous cell carcinoma in a metastatic site, regardless of whether the primary site is known or unknown. This groundbreaking work highlights his commitment to advancing cancer diagnostics.

Career Highlights

He is currently affiliated with the H. Lee Moffitt Cancer Center and Research Institute, Inc., where he continues to engage in impactful research. His work is crucial in the ongoing battle against cancer, providing new insights and methodologies that can aid in treatment decisions.

Collaborations

Jasreman Dhillon collaborates with esteemed colleagues such as Yin Xiong and Anthony M Magliocco. These partnerships enhance the research environment and foster innovation in cancer treatment strategies.

Conclusion

Jasreman Dhillon's contributions to cancer research through his patented methods exemplify the importance of innovation in medicine. His work not only advances scientific understanding but also holds promise for improving patient care in oncology.